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A B S T R A C T
A practical approach to control glycemia in diabetes is to use plant natural products that delay hydrolysis of
complex sugars and promote the diminution of the release of glucosyl units into the blood plasma. Polyphenolics
have been described as being effective in inhibiting amylases and α-glucosidases. Grape pomace is an important
sub product of the wine industry, still rich in many compounds such as polyphenolics. In this context, the
purpose of this study was to search for possible effects of a grape pomace extract on salivary and pancreatic α-
amylases and α-glucosidase, as well as on intestinal glucose absorption. The Merlot grape pomace extract
(MGPE) was prepared using a hydroalcoholic mixture (40% ethanol + 60% water). In vitro inhibition was
quantified using potato starch (for amylases) and maltose (for α-glucosidase) as substrates. In vivo inhibition was
evaluated by running starch and maltose tolerance tests in rats with or without administration of MGPE. Ranking
of the extract compounds for its affinity to the α-amylases was accomplished by computer simulations using
three different programs. Both α-amylases, pancreatic and salivary, were inhibited by the MGPE. No inhibition
on α-glucosidase, however, was detected. The IC50 values were 90 ± 10 μg/mL and 143 ± 15 μg/mL for
salivary and pancreatic amylases, respectively. Kinetically this inhibition showed a complex pattern, with
multiple binding of the extract constituents to the enzymes. Furthermore, the in silico docking simulations in-
dicated that several phenolic substances, e.g., peonidin-3-O-acetylglucoside, quercetin-3-O-glucuronide and
isorhamnetin-3-O-glucoside, besides catechin, were the most likely polyphenols responsible for the α-amylase
inhibition caused by MGPE. The hyperglycemic burst, an usual phenomenon that follows starch administration,
was substantially inhibited by the MGPE. Our results suggest that the MGPE can be adequate for maintaining
normal blood levels after food ingestion.
1. Introduction
Diabetes is a well-known chronic disease that causes hyperglycemia
and modifies metabolism in a disordered way. The prevalence of dia-
betes mellitus steadily increases worldwide and has far-reaching con-
sequences for the quality of human life. Diabetes mellitus of type 2
(DM2) affects about 90% of patients diagnosed with the disease in high-
income countries (Ma et al., 2019). Hyperglycemia, the most visible
consequence of diabetes, originates several metabolic disturbances
(Giovannini, Howes, & Edwards, 2016). Many oral antidiabetic drugs
are used for controlling glycemia. These antidiabetics can be divided in
various classes according to their mechanisms of action: (1) insulin
secretagogues (e.g., sulphonylureas and postprandial glucose reg-
ulators), (2) compounds able to reduce insulin resistance (e.g., met-
formin and thiazolidinediones), (3) carbohydrate digestive enzymes
inhibitors (e.g., acarbose) (Campbell, 2007). The use of these drugs may
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present several degrees of efficiency, depending on each individual
case. Several of them act by means of various mechanisms, as for ex-
ample the soy isoflavones, which behave as insulin secretagoges and at
the same time are inhibitors of carbohydrate digestive enzymes
(Hamden, Jaouadi, Carreau, Aouidet, & Elfeki, 2011). On the other
hand, their use is not free of several side effects. The latter include
hypoglycemia, weight gain, edemas, lactic acidosis, cholestasis, folate
and B12 malabsorption, etc. Acarbose, which acts by inhibiting α-glu-
cosidase and α-amylase (respectively, EC. 3.2.1.20 and EC. 3.2.1.1),
causes abdominal discomfort, flatulence, meteorism and moderate
diarrhea. These may be the result of increased and abnormal fermen-
tation of semi digested carbohydrates in consequence of the action of
the gut microbiota (Sales, Souza, Simeoni, Magalhães, & Dâmaris,
2012). Such undesired effects very often cause discontinuation of
therapy. For this reason, the introduction of new inhibitors is highly
desirable.
In spite of the negative side-effects of acarbose, retardation of glu-
cose absorption during digestion has been widely considered a useful
and practical manoeuvre for controlling blood glucose concentration
(Lalegani, Gavlighi, Azizi, & Sarteshnizi, 2018). This is one more reason
for the present outstanding interest in plant-derived medicines and food
additives containing mixtures of inhibitors capable of inhibiting car-
bohydrate hydrolysing enzymes without causing the side effects of
acarbose. The idea is based on the hope that, if ingested as food or
during the meals in conjunction with food, their mild and paused action
may prevent accumulation of undigested carbohydrates. This, in turn,
would reduce the risk of excessive bacterial fermentation. Poly-
phenolics, including tannins of various types, flavonoids, catechins and
gallic acid among others, have been denoted as antioxidants and in-
hibitors of hydrolytic enzymes, especially of α-amylases and α-gluco-
sidase (Silva et al., 2014; Martinez-Gonzalez et al., 2017; Kato et al.,
2017; Kato-Schwartz et al., 2018; Shanmugam et al., 2018; Gutiérrez-
Grijalva, Antunes-Ricardo, Acosta-Estrada, Gutiérrez-Uribe, & Heredia,
2019; Li, Wang, et al., 2019; Cardullo et al., 2020; Zhu, Chen, Zhang, &
Huang, 2020).
Among grapes, Vitis vinifera is one of the most frequently cultivated
species for wine production (Barba, Zhu, Koubaa, Sant'Ana, & Orlien,
2016; Dulf, Vodnar, Toşa, & Dulf, 2020). The vitiviniculture branch of
activities generates many side-products, e.g., lees, rachis and pomace.
When their quantities are summed up, they correspond to approxi-
mately 30% of the vinified grapes (Drevelegka & Goula, 2020). This
material is still underexplored, and it is frequently discarded into the
environment, regardless of its negative impact (Beres et al., 2017).
Grape pomace, the most massive sub-product, comprises stems, skins
and seeds. As it is easy to deduce, this material still contains appreciable
amounts of phenolic compounds and other active principles (Corrêa
et al., 2017; Peixoto et al., 2018).
The phenolic compounds have been claimed to possess antioxidant,
antiradical, antitumor, anti-microbial, anti-aging, anti-inflammatory
and anti-tumoral properties and also of being able to exert cardiopro-
tective activity (Corrêa et al., 2018; Jara-Palacios et al., 2015; Ribeiro
et al., 2015; Zhao, Zhang, Zhang, He, & Duan, 2020). Previous in-
vestigations of our group, for instance, have identified several mole-
cules with potential functional properties in a Merlot (Vitis vinifera L.)
grape pomace hydroalcoholic extract (MGPE). The described com-
pounds include phenolic non-anthocyanins, such as various catechins,
as well as phenolic anthocyanins (Corrêa et al., 2017; Gonçalves et al.,
2017) (Table 1). The studied MGPE underwents more or less drastic
qualitative and quantitative modifications in its phenolic contents upon
digestion, as indicated by an in vitro digestion study (Corrêa et al.,
2017). Nonetheless, it is still markedly able to ameliorate the oxidative
state and to mitigate inflammation of arthritic rats (Gonçalves et al.,
2017).
Recently, extracts of several Brazilian native fruits such as
Campomanesia phaea, Eugenia dysenterica, Myrciaria dubia and Myrciaria
cauliflora have been reported to effectively inhibit α-amylases in in vitro
and in vivo (animal experiments and clinical studies) (Balisteiro, de
Araujo, Giacaglia, & Genovese, 2017). Similar results have been ob-
tained with extracts of red rice (Oryza sativa) (Liu et al., 2017), fig
leaves (Ficus benjamina) (Mumtaz et al., 2018), and apple fruits (Malus
domestica) (Li, Sun, et al., 2019). The polyphenols have generally been
considered the most important molecules involved in these effects (Sun,
Warren, & Gidley, 2019; Tresserra-Rimbau, Lamuela-Raventos, &
Moreno, 2018). On the other side, as long as we could find out, no
attempts have been done to investigate possible inhibitory activities of
grape pomace extracts on enzymes responsible for the hydrolysis of
carbohydrates that are important in type 2 diabetes. Considering this
gap, the purposes of the present work were to investigate the Merlot
grape pomace extract for its actions on three carbohydrate-hydrolysing
enzymes, more specifically salivary and pancreatic α-amylases and α-
glucosidase, as well as to assess its actions on intestinal glucose ab-
sorption. It should be remarked that potential health benefits for the
Merlot grape pomace also presents a sustainable alternative for its use.
Once an inhibitory effect has been detected, this primary observation
can be complemented by experiments aiming at understanding the
binding interactions involved in the inhibition.
2. Material and methods
2.1. Materials
Enzymes and most specific chemicals were obtained from Sigma-
Aldrich (St. Louis, USA): pancreatic α-amylase (porcine; Type VI-B;
A3176), salivary α-amylase (human; A1031), maltose (M5885), glucose
(G8270), potato starch (85642) and acarbose (C25H43NO18, mw 645;
A8980). Gold Analisa was purchased from Labtest Brazil. Samples of
Merlot grape pomace (Vitis vinifera) were obtained from companies
established in the Paraná State, Brazil. The grapes had been harvested
and pressed in 2013. In the laboratory, drying was done in a convection
oven (Marconi MA 035, Brazil) at 80 °C for 36 h. After milling, the
material was packed in polyethylene film bags under vacuum with
subsequent storing at −20 °C until use (Ribeiro et al., 2015).
Table 1
Daily doses of phenolic compounds, non-anthocyanins and anthocyanins, ad-
ministered to the animals*.
Daily dose of each compound (mg/kg)
Compound 50 mg/kg dose 250 mg/kg dose
Non-anthocyanin phenolic compounds
Galloylshikimic acid 0.17 0.84
B-type (epi)catechin dimers (4 isomers) 1.28 6.36
Digalloylquinic acid 0.12 0.58
(+)-Catechin 0.36 1.82
Digalloylshikimic acid 0.09 0.47
(−)-Epicatechin 0.37 1.83
B-type (epi)catechin trimers (2 isomers) 0.43 2.13















*Values were calculated from the corresponding contents of the grape pomace
aqueous extract reported in a previous work (Corrêa et al., 2017).
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2.2. Merlot grape pomace extract preparation
The Merlot grape pomace extract (MGPE) was prepared as described
before (Gonçalves et al., 2017). A full characterization of the extract in
terms of its non-anthocyanins and anthocyanin constituents by HPLC-
DAD-MS analysis has already been reported (Gonçalves et al., 2017).
Names and amounts of the identified compounds are given in Table 1.
In this list the B-type (epi)catechin dimers (4 isomers) and B-type (epi)
catechin trimers (2 isomers) were added together.
2.3. Initial reaction rates of α-amylases
Initial reaction rates catalyzed by both α-amylases, human salivary
and porcine pancreatic, were measured at temperature (37 °C) and pH
(6.9) close to the optima reported previously (Silva et al., 2014). The
substrate was potato starch up to 1.0 g per 100 mL prepared in
20 mmol/L phosphate buffer plus 6.7 mmol/L NaCl. The amount of
enzyme added to each reaction mixture was 1 unit (specific activity
500 units/mg protein). After 10 min reaction, the amount of reducing
sugars in the reaction medium was quantified using the 3,5-dini-
trosalicylic acid procedure (Miller, 1959). The standard curve was
constructed with maltose. No changes in pH were observed along the
incubation time. Up to 250 μg/mL MGPE concentrations were used in
the various assays.
2.4. Isolation and assay of the intestinal α-glucosidase
The intestinal α-glucosidase (EC. 3.2.1.20) was isolated from the
small intestine of the rat as described previously (Kato-Schwartz et al.,
2020). For the α-glucosidase activity determination a glucose diagnosis
kit based on the glucose oxidase reagent was used as described (Kato-
Schwartz et al., 2020). The enzyme unit definition was based on the
universally accepted rules.
2.5. Kinetic evaluation of the inhibitory action of MGPE on the α-amylases
The inhibitor concentrations causing 50% inhibition (IC50) were
obtained by numerical interpolation using the Scientist program
(MicroMath Scientific Software (Salt Lake City, UT). Fitting of the rate
equations to the experimental initial rates of enzyme activity was done
using the traditional non-linear least-squares algorithm. The most
adequate equation was inferred from the standard deviations and model
selection criteria (MSC). The model selection criterion is usually de-








































Yobs, Ȳobs and Ycal are, respectively, the experimental, the mean ex-
perimental and the calculated reaction rates. The number of observa-
tions is represented by n and the number of parameters by p. The kinetic
mechanism with the largest MSC value was taken as the best description
of the experimental data.
2.6. Bioinformatics
The 3D structure of pancreatic α-amylase from pig at 1.38 Å re-
solution bonded to acarbose fragment (pseudotrisaccharide), was taken
from the Protein Data Bank (PDBid 1hx0) [PMID 11412124]. Next, the
human pancreatic α-amylase bonded to acarbose pentasacharide (ARE)
(PDBid 1xd0) (Li et al., 2005), was obtained and superimposed on the
porcine pancreatic α-amylase using Coot software (Emsley, Lohkamp,
Scott, & Cowtan, 2010). The coordinates of the ARE ligand was then
transfered to the pancreatic α-amylase (geometric docking) so the
resulting structure complex was used as a main target in virtual
screening simulations. Human salivary α-amylase (1.5 Å resolution;
pdbid: 3dhp) was used as secondary target in the docking studies to
evaluate the best compounds selected by virtual screening. All solvent
molecules (water) and ions were eliminated from the structures before
proceeding to the docking and virtual screening.
Three programs were used in the simulations: Autodock-v4.2.3
(Morris et al., 2009), implemented in the PyRx-0.9 graphical interface
(Dallakyan & Olson, 2015), Molegro-v6.0 Virtual Docker (Thomsen &
Christensen, 2006) and Gold-v5.4.0 (Jones, Willett, Glen, Leach, &
Taylor, 1997). The choice for search and scoring functions in each
program was accomplished through redocking of the ARE ligand onto
the previously modelled porcine pancreatic α-amylase complex. The
protocol was considered to be validated when the best ranked pose
provided a root mean-square deviation below 2.0 Å in all repetitions.
For Molegro, the Moldock Score [grid] and Iterated Simplex were se-
lected as scoring and search algorithms, respectively. The search was
adjusted to 10 runs, while other parameters were set as default. A
search radius of 12 Å centralized at the reference ligand (ARE) was
used. For Autodock, the search box was centered at the ligand, with x, y
and z axes having grid dimensions of 50. The number of runs was in-
creased to 50 and the number of energy evaluations was set to
2,500,000 (medium). The latter is justified by the large number of ro-
tatable bonds of the ligands. Finally, for Gold, the selected scoring
function was Chemplp (with ASP as rescore), the search efficiency was
adjusted to 200% and the binding site was defined as all atoms within
10 Å from the reference ligand.
A virtual library of compounds was built using the molecules
identified by HPLC-DAD-MS in the MGPE (Gonçalves et al., 2017).
Their tridimensional structures were obtained from PubChem (Kim
et al., 2019) or Zinc15 (Sterling & Irwin, 2015) databases. The struc-
tures of 19 compounds were downloaded, including procyanidin B2,
the [epicatechin-(4β→8)-epicatechin] dimer, which served as the basis
for drawing the β-type (epi)catechin trimer and β-type (epi)catechin
tetramer compounds using Marvin Sketch program. The final library
containing 21 molecules was then, virtually screened using the vali-
dated protocols established by redocking.
2.7. Animal experiments
Male Wistar rats (200–250 g) were used in all experiments. During
the whole experimental time the animals were kept in individual cages
with free access to water and standard pelleted food. The experiments
were preceded by a fasting period of 18 h. The experiments were ap-
proved by the Ethics Committee for Animal Experimentation of the
University of Maringá (Protocol number 067/2014-CEUA-UEM), which
obeys the universally recommended rules for animal experimentation
and is in full accordance with the Brazilian regulations on the subject.
2.7.1. Evaluation of glucose in blood
Blood glucose concentration was measured at time zero and at
various times following the administration of carbohydrates and in-
hibitors. The carbohydrates were starch, maltose and glucose. The in-
hibitors were acarbose and pomace extract. Blood was collected from
the tail vein at times 0, 15, 30, 45, and 60 min. Glucose was quantified
by means of an Accu-Chek® Active Glucose Meter.
2.7.2. Blood glucose concentration after starch administration
Intragastric administration was used throughout. The following
experimental conditions were used: (1) controls, rats receiving corn
starch (1 g per kg body weight); (2) negative controls, animals receiving
tap water; (3) positive controls, 4 animals receiving corn starch plus
acarbose (50 mg/kg); (4) test animals receiving corn starch plus 50 mg/
kg MGPE; (5) test animals receiving corn starch plus 250 mg/kg MGPE.
Four rats were used for each experimental protocol (n = 4). The de-
cision on the doses of acarbose and MGPE was based on previous
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experiments. Glucose concentration in blood was determined as de-
scribed in item 2.7.1.
2.7.3. Blood glucose concentration after maltose administration
The following experimental conditions were used: (1) controls, rats
receiving maltose (1 g per kg body weight); (2) negative controls, an-
imals receiving tap water; (3) test animals receiving maltose plus
250 mg/kg MGPE; (4) test animals receiving maltose plus 500 mg/kg
MGPE. Four rats were used for each experimental protocol (n = 4).
Glucose concentration in blood was determined as described in item
2.7.1.
2.7.4. Glycemic levels after glucose feeding
The following experimental conditions were used: (1) controls, rats
receiving glucose (1 g per kg body weight); (2) negative controls, ani-
mals receiving tap water; (3) test animals receiving glucose plus MGPE
at the dose of 100 mg/kg; (4) test animals receiving glucose plus MGPE
at the dose of 500 mg/kg. Four rats were used for each experimental
protocol (n = 4). Glucose concentration in blood was determined as
described in item 2.7.1.
2.8. Statistical analysis
The GraphPad Prism software (version 8.0) was used in the com-
putations. Significant differences were inferred from the Tukey test for
homogeneous data and from the Kruskal–Wallis test for heterogeneous
data after one-way ANOVA. Significance was accepted when p ≤ 0.05.
3. Results and discussion
3.1. In vitro inhibition of the activities of carbohydrate digestive enzymes by
the grape pomace extract
The actions of the grape pomace extract on the activities of the
various enzymes investigated in this work are shown in Fig. 1. The
inhibitor concentration dependences were determined by fixing the
starch concentration at 1 g/100 mL and by varying the concentrations
of MGPE in the range up to 250 µg/mL. In Fig. 1A the residual enzy-
matic activities were plotted versus the inhibitor concentration. Both
amylases were inhibited by the grape pomace extract with clear con-
centration dependences. Inhibition of the salivary amylase was more
pronounced than that of the pancreatic amylase; the IC50 values were
90 ± 10 μg/mL for the first one and 143 ± 15 µg/mL for the latter.
The effects of the MGPE on the intestinal α-glucosidase are also shown
in Fig. 1A. In the pertinent experiments the concentration dependence
was determined by fixing the maltose concentration at 25 mM and by
varying the concentration of the grape pomace extract in the range up
to 250 µg/mL. Clearly, no inhibition was observed (p ≥ 0.05).
The representation of 1/v against the inhibitor concentration in
Fig. 1B was done in order to infer in a preliminary way about the kinetic
equation that describes the inhibition caused by the MGPE. With both
enzymes a parabolic relationship was found, indicating that the rate
equation must contain at least one quadratic [I] term (Plowman, 1972).
It is worth mentioning that this phenomenon does not reflect the het-
erogeneity of the MGPE provided that the proportion between the
various compounds is not changed (Plowman, 1972). With this pre-
liminary notion in mind and for extending analysis, initial reaction
rates were quantified by varying simultaneously the inhibitor and
substrate concentrations. Fig. 2A displays the results using the human
salivary α-amylase. Two different inhibitor concentrations were tested,
as indicated on the graph. The usual saturation curves were found. The
latter do not converge at the highest substrate concentrations, an ob-
servation that rules out competitive inhibition. In consequence, equa-
tions describing mixed inhibition were fitted to the experimental
curves. Fitting was simultaneous, this includes the v × [S] relationship
as well as the v × [I] relationship. The rate equation yielding the best
fit to the experimental curves was one containing solely one quadratic
term for [I]:
=
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In Eq. (2) KM and Vmax represent, as usual, the Michaelis-Menten
constants and the maximal reaction rate, respectively. The apparent
inhibition constants are Ki1, ′Ki1 and Ki2, whose meaning is certainly
very complex, but that bear relation to the true dissociation constants of
complexes EI, EI2 and ESI, respectively. The legend to Fig. 2 lists the
optimized values of each parameter. The complex ESI2 could not be
detected, as the fitting procedure invariably returned Ki2′ values ex-
ceeding by several orders of magnitude the other constants and with a
standard deviation exceeding its optimized value by far. The lines
running through the experimental points in both panels of Fig. 2 are the
calculated curves. There is good agreement between theory and ex-
periment, including the v × [I] relationship. If the optimized para-
meters displayed in the legend to Fig. 2 are substituted into equation
(2), it will be possible to predict the reaction rates for any combination
of starch and extract concentrations. Comparison of the optimized
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Fig. 1. Concentration dependences of the effects of the grape pomace extract on
the activities of porcine pancreatic α-amylase, human salivary α-amylase and
α-glucosidase. Each datum point is the mean of four determinations. Reaction
rates (v; panel A) and reciprocals of the reaction rates (1/v; panel B) were
represented against the grape pomace extract concentration ([I]).
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values of Ki1, Ki2 and ′Ki1 indicates that formation of the EI complex is
the most likely phenomenon at low concentrations of the inhibitor or
mixture of inhibitors as the Ki1/Ki2 ratio is equal to 0.141. Formation of
the ESI and EI2 complexes is less likely, but will certainly occur at
concentrations above 100 μg/mL.
The initial rates of the reaction catalyzed by the porcine pancreatic
α-amylase at varying substrate and inhibitor concentrations are shown
in Fig. 3A. The general pattern is similar to that obtained for the sali-
vary enzyme. Attempts at fitting Eq. (2) to the data failed, however, as
failed attempts at fitting several equations containing individualized
inhibitor constants. The only equation that could be fitted was one
containing the average composite inhibition constants, K̄i1 and K̄i2 , in
combination with quadratic [I] terms (Desseaux, Koukielkolo, Moreau,
Santimoni, & Marchis-Mouren, 2002; Silva et al., 2014):
=


















Indicators of fitting goodness and the optimized values of the var-
ious parameters are given in the legend to Fig. 3. Comparison of ex-
periment and theory is allowed by Panels A and B in Fig. 3 because the
continuous lines were computed after substituting the optimized para-
meters into Eq. (3). As in the preceding case of the salivary enzyme,
there is a relatively good agreement between theory and experiment,
including the v × [I] relationship. Prediction of the inhibition degree at
various substrate and inhibitor concentrations by means of Eq. (3) is,
thus, a real possibility. The composite inhibition constants K̄i1 and K̄i2
have a complex meaning (Desseaux et al., 2002; Silva et al., 2014). In
principle, they can be taken as indicating that complexes of the type
EI2, ESI2 or of higher order amply predominate when the MGPE is
present in the reaction medium. As it was the case with the salivary
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Fig. 2. Reaction rates of the human salivary α-amylase obtained by varying
simultaneously the substrate (starch) and the grape pomace extract con-
centrations. Each datum point is the mean of four determinations. The lines
running through the experimental points were calculated using optimized
parameters obtained by fitting Eq. (2) to the experimental data by means of a
nonlinear least-squares procedure. Values of the optimized parameters and
goodness of fit indicators are KM, 0.321 ± 0.040 g/100 mL; Vmax,
0.703 ± 0.032 μmol/min; Ki1, 30.75 ± 6.65 μg/mL; Ki2,
217.43 ± 129.05 μg/mL; ′Ki1, 244.71 ± 86.91 μg/mL; sum of squared de-
viations, 0.0104; MSC, 3.893.





































[S] = 1 g/100 mL
Fig. 3. Reaction rates of the porcine pancreatic α-amylase obtained by varying
simultaneously the substrate (starch) and the grape pomace extract con-
centrations. Each datum point is the mean of four determinations. The lines
running through the experimental points were calculated using optimized
parameters obtained by fitting Eq. (3) to the experimental data by means of a
nonlinear least-squares procedure. Values of the optimized parameters and
goodness of fit indicators are KM, 0.171 ± 0.017 g/100 mL; Vmax,
0.663 ± 0.017 μmol/min; K̄i1, 72.99 ± 29.00 μg/mL; K̄i2 ,
187.0 ± 84.8.1 μg/mL; sum of squared deviations, 0.0107; MSC, 4.105.
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enzyme, complexation with the free pancreatic α-amylase also occurs
more easily than binding to the enzyme-substrate complex, as K̄i1/K̄i2
equals 0.39. On the other hand, the values of the inhibitor constants
obtained with both enzymes are compatible with the stronger inhibition
observed with the salivary α-amylase. Binding of the extract compo-
nents to the free salivary enzyme, for example, is (72.99/30.75 = )
2.37 times more likely than the same phenomenon with the pancreatic
enzyme.
Even considering the heterogeneity of the preparation that was used
here, it should be remarked that this fact does not invalidate the use of
Eqs. (2) and (3), provided that the proportions between the con-
centrations of the active compounds are not modified, a condition that
holds whenever various quantities of a given preparation are used
(Cleland, 1963; Plowman, 1972). The inhibition constants under such
circumstances, however, will have a quite complex significance. They
are in fact complex functions of several individual dissociation con-
stants and factors relating the total weight of the extract and its content
in active principles. Even so they are still a measure of the strength of a
given preparation expressed in terms of the extract mass that was
added, as can be readily deduced by means of the general algorithms of
steady-state enzyme kinetics (Chou & Talalay, 1977; Cleland, 1963;
Plowman, 1972). At this point it is worth to compare the results of the
present study with those reported by our group about acarbose, a well
described inhibitor of α-amylases (Silva et al., 2014). Acarbose is a
much stronger inhibitor of both salivary and pancreatic α-amylases,
with inhibition constants in the range of up to 10 μg/mL. However, it
also binds to both the free and to the enzyme already complexed with
the substrate and, in the case of the pancreatic enzyme, the inhibition is
parabolic with the formation of complexes EI2, ESI2 or higher.
3.2. In silico studies
As mentioned at Introduction, the chemical composition of the
MGPE is quite complex (Table 1) and the isolation of the various
compounds for testing their inhibitory activity on the α-amylases can be
quite laborious. A most convenient approach would be to infer initially
from computer simulations what are the most likely compounds (or
compound) to be acting as inhibitors of the α-amylases.
As a starting strategy redocking simulations were used for selecting
the docking programs and protocols. This procedure consists in docking
a ligand that is already present in a crystallographic or modelled
structure. If the program succeeds in “understanding” the forces that
drive the interactions among protein and ligand, the results will be a
best pose that matches the modelled/crystallographic one in all re-
petitions. A successful redocking simulation suggests that the docking
protocol can be used to evaluate unknown ligands from a virtual li-
brary. In this work, the redocking method was repeated four times in
each program and the results are summarised in Table S1. All three
programs were able to redock the acarbose pentasaccharide ligand on
the porcine pancreatic α-amylase binding site (Fig. S1). Thus, the
docking protocols were applied to evaluate the grape extract molecules
present in our virtual library composed by 21 molecules. To select the
most promising ligands, we considered not only score values, but also
the reproducibility in all repetitions using every program. Since each
one uses a distinct set of algorithms to predict binding poses and scores,
when different programs can reproduce a similar result repeatedly, it is
more likely that they are true-positives. The best results found from
virtual screening are displayed in Table 2 and their structures are re-
presented in Fig. S2. A remark should be made with respect to the B-
type (epi)catechin dimers, trimers and tetramer in the extract (Table 1).
The (epi)catechin pharmacophore group was not selected by virtual
screening as a potential candidate for inhibitor. Consequently, there
was also no justification for exploring different possibilities for the ar-
rangement of the B-type oligomers.
The molecule that yielded the most promising scores was peonidin-
3-O-acetylglucoside (P3A, Fig. S3-A), an anthocyanin that belongs to
the class of phenolic compounds usually known as flavonoids (Ghosh &
Konishi, 2007). Anthocyanins are water-soluble pigments with potent
antioxidant properties that provide health benefits in cases of in-
flammation, obesity and diabetes mellitus (Gowd, Jia, & Chen, 2017).
There are literature reports that other anthocyanins, such as cyanidin-3-
glucoside (C3G) and peonidin-3-glucoside (P3G), could competitively
inhibit the porcine pancreatic α-amylase in vitro, with IC50 values of
24 µM and 75 µM, respectively (Sui, Zhang, & Zhou, 2016). Both P3G
and C3G share the same anthocyanin backbone (Fig. S3-B), differing
only in the R group on C3′ (B ring), while P3G and P3A differ only in
the acetyl group on C6′' (glucoside).
Based on these observations, we decided to further investigate if
C3G (which was not identified in the grape Merlot extract), as well as
P3G, which is present in the extract, would show similar results as P3A
using docking simulations. The structures were evaluated using the
validated protocols described earlier and the results of the calculations
are displayed in Table S2. In all simulations, P3A showed the highest
score and its best pose was similar to C3G and P3G (Fig. S4). The fact
that all three anthocyanins assume practically the same poses from all
three programs that were used, suggests they are stabilized by the same
interactions in the active site, also known as the binding cleft, which
lies near the protein centre and can be characterized by the catalytic
residues Asp197, Glu233 and Asp300 (Larson, Day, & McPherson,
2010). Fig. 4 shows the P3A docked in the porcine pancreatic α-amy-
lase active site surrounded by side chains residues. All programs
showed that the P3A was surrounded by the same three catalytic re-
sidues and also in vicinity to the lateral chains of Lys200, Arg195,
Gln63 and His305.
Pancreatic α-amylase is a better target for the development of in-
hibitors with antihyperglycemic activity regarding salivary α-amylase
(Qin et al., 2011), given its longer half-life/activity in the duodenum
lumen. Furthermore, there is no crystallographic structure of the sali-
vary α-amylase bonded to our control inhibitor ACA deposited in the
PDB. Therefore, in our virtual screening simulations, we used pan-
creatic α-amylase as the main target. However, after virtual screening,
the best ranked ligands were equally docked on the salivary α-amylase
where they presented poses quite close to that seen in the pancreatic α-
amylase, with a characteristic cluster of conformation (Fig. S5).
Based on our docking simulations, it can be deduced that the an-
thocyanins are able to block the α-amylase catalytic site. In principle,
however, this is equally valid for catechin, which is considerably more
abundant in the MGPE than any individual anthocyanin (Table 2). Al-
though the affinity of a protein for a ligand can only be accurately es-
timated by more sensitive calculation methods such as Linear Interac-
tion Energy (LIE) (Gutiérrez-de-Terán & Åqvist, 2012) or Molecular
Mechanics Poison-Boltzmann Surface Area (MM-PBSA) (Kumari et al.,
2014), the docking simulations provide important clues to find the
protein binding site and to understand its interaction with the ligands.
Docking simulations also contribute to devise the most likely con-
formation that a given ligand may assume on binding. The scores ob-
tained for the various ligands described in Table 2 are relatively close.
This suggests competition between themselves or with the substrate for
the enzyme active site. Although binding is equally possible in the
presence of substrate, as indicated by the kinetic data that revealed a
mixed type of inhibition, binding in the absence of substrate is con-
siderably stronger, as revealed by the fact that the pertinent apparent
dissociation constants for the EI complexes (Ki1 and K̄i1 ) are smaller for
both enzymes than the apparent dissociation constants for the ESI
complexes (see legends to Figs. 2 and 3).
The interactions described so far could, thus, explain the inhibitory
activity of the Merlot grape pomace extract on the α-amylases and
provide useful information for the development of new inhibitors. Even
though P3G, C3G and P3A have similar chemical structures and showed
overlapping binding poses, P3A seems to have a significantly higher
docking score for binding to the active site, based on the results from
three different softwares. Catechin, on the other hand, presents
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relatively lower docking scores compared to the three anthocyanins
(Table 2), but its relative abundance in the MGPE (Table 1) does not
allow to exclude its participation in the inhibitory activity.
3.3. In vivo inhibition of the activities of carbohydrate digestive enzymes by
the grape pomace extract
It is important to find out if the effects of MGPE on the α-amylases
have physiological relevance, i.e., if they also occur in vivo. An ex-
perimental approach that is likely to produce an answer to this question
is to quantify the appearance of glucose in blood after feeding animals
with starch. Similarly, due to the virtual absence of effects on α-glu-
cosidase, no modifications in blood glucose levels should occur upon
maltose administration. This reasoning resides on the generally ac-
cepted notion that the action of hydrolytic enzymes in the intestinal
tract is essential for the absorption of the individual molecular con-
stituents of di-, oligo- and polysaccharides. Table 1 shows the daily
doses of phenolic non-anthocyanins and anthocyanins compounds that
were automatically administered as part of the 50 or 250 mg extract per
kg weight that were given to the animals.
Figs. 5–7 illustrate the results of the experiments that were done in
the search for answers regarding the question formulated above. Ad-
ministration of starch alone (Fig. 5A) produced the control curve in
which the blood glucose concentration increased up to a maximal value
(at 30 min) which was 90% above the basal concentration. The de-
clining tendency was yet not complete at 60 min as the glucose con-
centration was still considerably above the basal line. Water adminis-
tration did not perturb the blood glucose concentrations in a significant
way during the period of 60 min. A smaller increase in the blood levels
of glucose was found when starch and 50 mg/kg of MGPE were given
simultaneously (p≤ 0.05). When the MGPE dose was raised to 250 mg/
kg, the events were somewhat modified with an initial delay and
smaller levels at the end (60 min). The effects of this dose were close to
the modifications caused by acarbose. Panel B in Fig. 4 shows the areas
under the various time-response curves obtained after starch adminis-
tration under various conditions, diminished from area under the curve
when solely water was administered. Both MGPE doses significantly
reduced the areas under the curves. The diminutions at the doses of 50
and 240 mg/kg performed, respectively, 37.1 and 71.4%.
Contrarily to what was observed with starch, simultaneous admin-
istration of MGPE and maltose did not cause any reduction in blood
glucose levels (Fig. 6). This observation is consistent with the in vitro
assays, in which the α-glucosidase activity was not negatively affected
by the extract (Fig. 1). Finally, Fig. 7 shows that MGPE had no in-
hibitory effect when administered simultaneously with glucose. These
in vivo studies reinforce the idea that the grape pomace extract acts by
inhibiting amylase activity, but does not present any inhibitory action
on alpha-glucosidase and does also not interfere with glucose absorp-
tion.
The phenolic composition of the grape pomace extract used in this
work has already been described by Corrêa et al. (2017) and Gonçalves
et al. (2017). The most abundant phenolic compounds were epica-
techin, catechin, quercetin, myricetin, isorhamnetin glycoside deriva-
tives, malvidin-3-O-glucoside and peonidin-3-O-glucoside. The prob-
able participation of catechin and several anthocyanins in the inhibition
of α-amylases has already been discussed above. Considering the type
of molecules found in the extract, the results obtained in this study
partially diverge with the general concept that phenolic compounds,
such as flavonoids and polyphenols, have the ability of inhibiting the α-
glucosidase activity (Ishikawa et al., 2007; Hargrove, Greenspan,
Hartle, & Dowd, 2011; Kumar, Narwal, Kumar, & Prakash, 2011; Yin,
Zhang, Feng, Zhang, & Kang, 2014; Kadouh, Sun, Zhu, & Zhou, 2016;
Martinez-Gonzalez et al., 2017; Li, Wang, et al., 2019; Zhu et al., 2020).
It should be stressed, however, that there are reports showing that the
intestinal enzyme and the yeast enzyme generally present different
sensitivities to flavonoids and polyphenols (Babu et al., 2004; Tadera,
Minami, Takamatsu, & Matsuoka, 2006). Tadera et al. (2006), for ex-
ample, reports that the rat intestinal α-glucosidase is slightly inhibited
by a great number of flavonoids, and only minimally by anthocyanidin
and isoflavone groups. The yeast enzyme, on the contrary, is strongly
inhibited by isoflavone, anthocyanidin and flavonol groups. It seems,
thus, that the grape pomace extract used in the present work presents a
combination of constituents that are inactive on the intestinal α-glu-
cosidase within the concentration range that was used. Furthermore,
there are reports that the substrate may equally influence the degree of
inhibition (Tadera et al., 2006). In the present study, maltose was used
because this is the physiological substrate. In many studies in the past,
however, synthetic substrates such as p-nitrophenyl-α-D-
Table 2
Molecules selected from virtual screening after four repetitions using three programs on two α-amylase targets.
Selected compounds Autodock score Molegro score Gold score
Docking using porcine pancreatic α-amylase
Peonidin-3-O-acetylglucoside (P3A) −8,40 ± 0,14a −156,00 ± 1,90a 81,46 ± 0,84a
Isorhamnetin-3-O-glucoside (I3G) −7,26 ± 0,27b −131,12 ± 0,20b 74,83 ± 1,98b
Quercetin-3-O-glucuronide (Q3G) −7,07 ± 0,18b −137,70 ± 0,42c 70,47 ± 0,41c
Catechin (KTC) −7,44 ± 0,02c −102,17 ± 0,10d 66,12 ± 1,05d
Docking using human salivary α-amylase
Peonidin-3-O-acetylglucoside (P3A) −8.46 ± 0.09a −172.95 ± 4.06a 84.89 ± 1.53a
Isorhamnetin-3-O-glucoside (I3G) −7.09 ± 0.10b −144.49 ± 0.17b 72.27 ± 2.80b
Quercetin-3-O-glucuronide (Q3G) −7.38 ± 0.20c −142.11 ± 0.06c 70.91 ± 1.94b
Catechin (KTC) −7.17 ± 0.02b −98.88 ± 0.18d 63.24 ± 0.41c
Different letters in the same column mean statistical difference (p < 0.05).
Fig. 4. Best ranked pose of peonidin-3-O-acetylglucoside (P3A) docked on the
catalytic binding site of the porcine pancreatic α-amylase. The catalytic re-
sidues Asp197, Asp300 and Glu233 are in close contact with P3A.
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glucopyranoside were used a fact that might have influenced the in-
hibition degree.
The results of the present study add both in vitro and in vivo evidence
about the action of flavonoids and other polyphenolics of various kinds
on postprandial glycemia after the ingestion of starch, but not maltose
or glucose (Silva et al., 2014; Kato et al., 2017; Martinez-Gonzalez
et al., 2017; Kato-Schwartz et al., 2018; Shanmugam et al., 2018;
Gutiérrez-Grijalva et al., 2019; Li, Wang, et al., 2019; Cardullo et al.,
2020; Zhu et al., 2020). That flavonoids and polyphenolics in general
may affect glycemia by inhibiting starch hydrolyzing enzymes in vivo is
a widespread notion (Sun et al., 2019). An alternative or com-
plementary mechanism that has been suggested involves inhibition of
glucose transfer from the intestinal lumen to the cells, which is ac-
complished by glucose transporters in the enterocytes of the small in-
testine (Sun et al., 2019). A direct inhibitory action on these trans-
porters was excluded by the glucose tolerance experiments in the
present work, which revealed no diminutions in the rate of glucose
appearance in blood after the MGPE administration. It still remains the
possibility of an inhibition of the expression of the glucose transporters
(Sun et al., 2019). In the present work, however, only short-term effects
were examined and gene expressions are medium- or long-term
phenomena. Clearly, this is a question that has to be answered by future
specific experiments.
4. Conclusion
In conclusion, MGPE can be regarded as an inhibitor of both the
salivary and the pancreatic α-amylases, but not of the α-glucosidase
enzyme. Kinetically the inhibition showed a complex pattern, with
multiple binding of the extract constituents to the enzymes.
Furthermore, the in silico docking studies indicated that some antho-
cyanin compounds, such as peonidin-3-O-acetylglucoside, quercetin-3-
O-glucuronide and isorhamnetin-3-O-glucoside, in addition to catechin,
were the most likely polyphenols responsible for the α-amylase in-
hibition caused by MGPE. Finally, MGPE had also a negative effect on
starch hydrolysis in vivo, as it diminished the increases in glucose levels
that followed starch administration. These findings are supportive to
the hypothesis that MGPE could adequate as an adjuvant for keeping
normal glycemia and may serve as the basis for clinical trials.


















































Fig. 5. Influence of MGPE and acarbose administration on the glycemic levels of fasted rats during 60 min following starch administration. Blood samples from the
tail vein were analyzed by means of a glucometer after intragastric starch administration (1 g per kg body weight). Each datum point represents the mean ± mean
standard errors of three experiments. (●,1) Starch alone; (○) water alone; (▲, 4) starch plus 50 mg/kg acarbose; (□,2) starch plus 50 mg/kg MGPE; (■,3) starch
plus 250 mg/kg MGPE. Experimental details are given in the Materials and methods section. In B, all values are statistically different from each other (p ≤ 0.05).



















































Fig. 6. Influence of MGPE administration on the glycemic levels of fasted rats during 60 min following maltose administration. Blood samples from the tail vein were
analyzed by means of a glucometer after intragastric starch administration (1 g per kg body weight). Each datum point represents the mean ± mean standard errors
of three experiments. (●,1) Maltose alone; (○) water alone; (□,2) maltose plus 250 mg/kg MGPE; (■,3) maltose plus 500 mg/kg MGPE. Experimental details are
given in the Materials and methods section. In B, all values are not statistically different from each other (p ≤ 0.05).
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details are given in the Materials and methods section. In B, all values are not statistically different from each other (p ≤ 0.05).
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